🟢 Marker Therapeutics is trading 5.26% up today in pre-market as XBI rises 2.06%

Marker Therapeutics is trading 5.26% up at $1.60 in pre-market, following stronger biotechnology-sector sentiment as XBI rises 2.06%.

• Shares gained 1.33% during the August 25 regular session.
• No new company-specific announcement was identified for August 25–26, 2026; the latest listed release is dated March 18, 2026.
• H.C. Wainwright reiterated Buy and a $10 target on August 21, before the move.